These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 9270901)

  • 41. Functional antagonistic properties of clozapine at the 5-HT3 receptor.
    Hermann B; Wetzel CH; Pestel E; Zieglgänsberger W; Holsboer F; Rupprecht R
    Biochem Biophys Res Commun; 1996 Aug; 225(3):957-60. PubMed ID: 8780717
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of amperozide on rat cortical 5-HT2 and striatal and limbic dopamine D2 receptor occupancy: implications for antipsychotic action.
    Meltzer HY; Zhang Y; Stockmeier CA
    Eur J Pharmacol; 1992 May; 216(1):67-71. PubMed ID: 1388121
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Receptor binding profile of tibalosine, a new antihypertensive.
    Chatelain P; Friedhoff AJ; Meller E; Mennini T; Gorissen H; Roba J
    Arzneimittelforschung; 1984; 34(7):754-8. PubMed ID: 6093823
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biochemical and electrophysiological studies of the psychotropic compound, amperozide.
    Haskins JT; Muth EA; Andree TH
    Brain Res Bull; 1987 Oct; 19(4):465-71. PubMed ID: 2825928
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interaction of piracetam with several neurotransmitter receptors in the central nervous system. Relative specificity for 3H-glutamate sites.
    Bering B; Müller WE
    Arzneimittelforschung; 1985; 35(9):1350-2. PubMed ID: 3002398
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of amperozide, a new antipsychotic drug, on plasma corticosterone concentration in the rat.
    Albinsson A; Andersson G
    Life Sci; 1992; 51(19):1535-44. PubMed ID: 1359366
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Behavioral and biochemical effects of amperozide and serotonin agents on nigrostriatal and mesolimbic dopamine systems.
    Chang PY; Chuang CH; Chen JC; Tung CS
    Chin J Physiol; 2008 Apr; 51(2):106-15. PubMed ID: 18666714
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biochemical pharmacology of pirenzepine. Similarities with tricyclic antidepressants in antimuscarinic effects only.
    Bechtel WD; Mierau J; Pelzer H
    Arzneimittelforschung; 1986 May; 36(5):793-6. PubMed ID: 3755340
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Amperozide, a putative anti-psychotic drug: uptake inhibition and release of dopamine in vitro in the rat brain.
    Eriksson E
    Life Sci; 1990; 47(23):2111-7. PubMed ID: 1979998
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors.
    Roth BL; Craigo SC; Choudhary MS; Uluer A; Monsma FJ; Shen Y; Meltzer HY; Sibley DR
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1403-10. PubMed ID: 7908055
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro and in vivo pharmacological profile of 4-(4-fluorobenzylidene)-1-[2-[5-(4-fluorophenyl)-1H-pyrazol-4-yl] ethyl] piperidine (NRA0161).
    Suzuki Y; Funakoshi T; Chaki S; Kawashima N; Ogawa S; Kumagai T; Nakazato A; Komurasaki T; Okuyama S
    Life Sci; 2002 Oct; 71(22):2603-15. PubMed ID: 12354579
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Amperozide influences feeding independently of 5-HT2A receptor antagonism.
    Price IV; Gorzalka BB; White SJ; Arkinstall KH
    Neuropsychobiology; 1998; 37(3):155-9. PubMed ID: 9597673
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Selective down-regulation of the agonist-dependent high affinity state of rat cortical 5-HT2 receptors following chronic treatment with amperozide.
    Svartengren JO
    J Recept Res; 1993; 13(1-4):379-92. PubMed ID: 8450497
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Amperozide, a 5-HT2 antagonist, attenuates craving for cocaine by rats.
    McMillen BA; Jones EA; Hill LJ; Williams HL; Björk A; Myers RD
    Pharmacol Biochem Behav; 1993 Sep; 46(1):125-9. PubMed ID: 8255902
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The putatively antipsychotic agent amperozide produces behavioural stimulation in the rat. A behavioural and biochemical characterization.
    Waters N; Pettersson G; Carlsson A; Svensson K
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Aug; 340(2):161-9. PubMed ID: 2572972
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanism of action of the benzodiazepines: behavioral aspect.
    Sepinwall J; Cook L
    Fed Proc; 1980 Oct; 39(12):3024-31. PubMed ID: 7418882
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency.
    Peroutka SJ; Synder SH
    Am J Psychiatry; 1980 Dec; 137(12):1518-22. PubMed ID: 6108081
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Amperozide--a new putatively antipsychotic drug with a limbic mode of action on dopamine mediated behaviour.
    Gustafsson B; Christensson E
    Pharmacol Toxicol; 1990; 66 Suppl 1():12-7. PubMed ID: 1968250
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuroleptic affinities for human brain receptors and their use in predicting adverse effects.
    Richelson E
    J Clin Psychiatry; 1984 Aug; 45(8):331-6. PubMed ID: 6146602
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds.
    Richelson E; Souder T
    Life Sci; 2000 Nov; 68(1):29-39. PubMed ID: 11132243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.